Kyntra Bio Inc stock is traded at $3.61, with a volume of 1,104. It is down -1.37% in the last 24 hours and down -39.43% over the past month. Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Previous Close:
$3.66
Open:
$3.62
24h Volume:
1,104
Relative Volume:
0.05
Market Cap:
$14.62M
Revenue:
$7.44M
Net Income/Loss:
-$56.57M
P/E Ratio:
0.13
EPS:
$27.47
Net Cash Flow:
-$21.40M
1W Performance:
-21.01%
1M Performance:
-39.43%
6M Performance:
-49.30%
1Y Performance:
0.00%
1-Day Range:
$3.61$3.65
1-Week Range:
$3.60$4.87
52-Week Range:
$3.60$9.70
Kyntra Bio Inc Stock (KYNB) Company Profile
Name
Kyntra Bio IncSector
HealthcareIndustry
BiotechnologyPhone
415-978-1200Address
350 BAY STREET, SAN FRANCISCO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS